Enovis reports 5% organic growth for Q2 2026, driven by strong performance in Recon and P&R segments, while maintaining 2026 outlook.
Enovis posted 5% organic growth in Q2 2026, led by a 6% rise in its Recon segment and 3% growth in P&R. The company attributed the results to a diversified product portfolio and expansion of its Arvis rollout.
Management reaffirmed its 2026 outlook, targeting over 25% free cash flow conversion. The prior quarter had not disclosed a specific organic growth rate, but the company had previously signaled confidence in sustained momentum.
No immediate market reaction was detailed in the earnings call summary.